Inhalation Ethanol therapy in COVID-19

Phase 3

Recruiting

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20210725051981N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

Positive RT-PCR test of SARS-COV2
Less than 7 days of starting of signs or symptoms of COVID-19
Age 15-69 yr

Exclusion Criteria

Pregnancy
History of Asthma
History of Alcohol dependency
History of Seizure
Contraindication of Ethanol addministration
Disagreement of patient physician

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Requires non-temporary hospitalization. Timepoint: Daily until 5 daus. Method of measurement: Counting the days.;Needing to ICU admission. Timepoint: Days 7, 14, 21. Method of measurement: Evaluate medical file records.;Mortality Rate. Timepoint: Days 7, 14, 21, 28. Method of measurement: Evaluate medical file records.;Respiratory status of patients. Timepoint: ?Days from 1 to 5. Method of measurement: SPO2.;Inflammatory condition. Timepoint: Days 1-5-14. Method of measurement: WBC counting -CRP titration.;Clinical status. Timepoint: Days 1-5-14. Method of measurement: Score from the table of clinical signs.